PolyPid Valuation
| PYPD Stock | USD 4.34 0.04 0.91% |
At this time, the company appears to be overvalued. PolyPid holds a recent Real Value of $4.06 per share. The prevailing price of the company is $4.34. Our model determines the value of PolyPid from analyzing the company fundamentals such as Return On Equity of -3.91, shares outstanding of 16.63 M, and Shares Owned By Institutions of 38.42 % as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that PolyPid's price fluctuation is slightly risky at this time. Calculation of the real value of PolyPid is based on 3 months time horizon. Increasing PolyPid's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the PolyPid stock is determined by what a typical buyer is willing to pay for full or partial control of PolyPid. Since PolyPid is currently traded on the exchange, buyers and sellers on that exchange determine the market value of PolyPid Stock. However, PolyPid's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 4.34 | Real 4.06 | Hype 4.34 | Naive 4.34 |
The real value of PolyPid Stock, also known as its intrinsic value, is the underlying worth of PolyPid Company, which is reflected in its stock price. It is based on PolyPid's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of PolyPid's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of PolyPid helps investors to forecast how PolyPid stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of PolyPid more accurately as focusing exclusively on PolyPid's fundamentals will not take into account other important factors: PolyPid Total Value Analysis
PolyPid is at this time projected to have valuation of 57.74 M with market capitalization of 72.19 M, debt of 9.62 M, and cash on hands of 23.78 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the PolyPid fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
57.74 M | 72.19 M | 9.62 M | 23.78 M |
PolyPid Asset Utilization
One of the ways to look at asset utilization of PolyPid is to check how much profit was generated for every dollar of assets it reports. PolyPid holds a negative application of assets of -0.88 pct., losing $0.008791 for each dollar of assets held by the company. Inadequate asset utilization implies the company is being less effective with each dollar of assets it holds. Put it differently, asset utilization of PolyPid shows how discouraging it operates for each dollar spent on its assets.PolyPid Ownership Allocation
PolyPid owns a total of 16.63 Million outstanding shares. 30% of PolyPid outstanding shares are owned by third-party entities. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.PolyPid Profitability Analysis
Net Loss for the year was (29.02 M) with profit before overhead, payroll, taxes, and interest of 0.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates PolyPid's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in PolyPid and how it compares across the competition.
About PolyPid Valuation
The stock valuation mechanism determines PolyPid's current worth on a weekly basis. Our valuation model uses a comparative analysis of PolyPid. We calculate exposure to PolyPid's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of PolyPid's related companies.PolyPid Ltd., a late-stage biopharma company, develops, manufactures, and commercializes products based on polymer-lipid encapsulation matrix platform to address unmet medical needs. PolyPid Ltd. was incorporated in 2008 and is headquartered in Petah Tikva, Israel. Polypid operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 75 people.
Complementary Tools for PolyPid Stock analysis
When running PolyPid's price analysis, check to measure PolyPid's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PolyPid is operating at the current time. Most of PolyPid's value examination focuses on studying past and present price action to predict the probability of PolyPid's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PolyPid's price. Additionally, you may evaluate how the addition of PolyPid to your portfolios can decrease your overall portfolio volatility.
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |